Longeveron Shares End 3-Day Win Streak, Drop 31% [MarketWatch]
Longeveron Inc. - Class A Common stock (LGVN)
Company Research
Source: MarketWatch
On Thursday, the company said the U.S. Food and Drug Administration granted rare-pediatric-disease designation to Lomecel-B for the treatment of hypoplastic left heart syndrome. Volume for the stock was 8.4 million shares at 10:35 a.m. ET, compared with its 65-day average volume of eight million shares. The stock hit its 52-week high of $28.52 Monday, and its 52-week low of $2.84 last Wednesday. The biotechnology company said Lomecel-B, an investigational allogeneic, bone marrow-derived medicinal signaling cell product, is currently being evaluated in a Phase 2 trial. Longeveron is evaluating the safety of Lomecel-B injection into the right ventricle during the second surgery, and the effect on cardiac function and other health status endpoints. Longeveron recently reported clinical results from its safety-focused Phase I clinical study of Lomecel-B in HLHS patients. When cardiac surgeons injected Lomecel-B directly into the babies' hearts at the time of surgery, the cells we
Show less
Read more
Impact Snapshot
Event Time:
LGVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGVN alerts
High impacting Longeveron Inc. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
LGVN
News
- Longeveron to Present at the Planet MicroCap Showcase [Yahoo! Finance]Yahoo! Finance
- Longeveron to Present at the Planet MicroCap ShowcaseGlobeNewswire
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering [Yahoo! Finance]Yahoo! Finance
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public OfferingGlobeNewswire
- Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds [Yahoo! Finance]Yahoo! Finance
LGVN
Earnings
- 11/10/23 - Miss
LGVN
Sec Filings
- 4/25/24 - Form D
- 4/18/24 - Form 8-K
- 4/18/24 - Form EFFECT
- LGVN's page on the SEC website